This paper is in the following e-collection/theme issue:

Secondary Use of Clinical Data for Research and Surveillance (450) Innovations in Clinical Trials and Research Data Management (116) Electronic Health Records (1267) New Technologies (103) Methods and Instruments in Medical Informatics (179) Clinical Informatics (1252) Design and Usability of Clinical Software and EHRs (333) Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (966) Design of Processes and Workflows (173)

Published on in Vol 12 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/52934, first published .
Data Flow Construction and Quality Evaluation of Electronic Source Data in Clinical Trials: Pilot Study Based on Hospital Electronic Medical Records in China

Data Flow Construction and Quality Evaluation of Electronic Source Data in Clinical Trials: Pilot Study Based on Hospital Electronic Medical Records in China

Data Flow Construction and Quality Evaluation of Electronic Source Data in Clinical Trials: Pilot Study Based on Hospital Electronic Medical Records in China

Authors of this article:

Yannan Yuan1 Author Orcid Image ;   Yun Mei2 Author Orcid Image ;   Shuhua Zhao1 Author Orcid Image ;   Shenglong Dai3 Author Orcid Image ;   Xiaohong Liu1 Author Orcid Image ;   Xiaojing Sun3 Author Orcid Image ;   Zhiying Fu1 Author Orcid Image ;   Liheng Zhou3 Author Orcid Image ;   Jie Ai2 Author Orcid Image ;   Liheng Ma3 Author Orcid Image ;   Min Jiang4 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Pfeffer M, Deneris M, Shelley A, Salcuni P, Altomare I. Utility of automated data transfer for cancer clinical trials and considerations for implementation. ESMO Real World Data and Digital Oncology 2025;7:100112 View
  2. Bailey C, Pearce I, Dinah C, Dodds M, Vidal-Brime L, Wilson A, Ellis J, Hall J, Pohler R, Shi B, Toshev D, Guymer R. Automated data collection from an electronic medical record for a prospective real-world study in patients with retinal disease (VOYAGER). Clinical Trials 2025 View